FDA panel backs much-debated ALS drug in rare, 2nd review
WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medicationthat was previously rejected by!-->…